Cargando…

Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells

BACKGROUND: Treatment-induced cardiotoxicity is a leading noncancer-related cause of acute and late onset morbidity and mortality in cancer patients on antineoplastic drugs such as melphalan—increasing clinical case reports have documented that it could induce cardiotoxicity including severe arrhyth...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Rui, Li, Dong, Sun, Fangxu, Rampoldi, Antonio, Maxwell, Joshua T., Wu, Ronghu, Fischbach, Peter, Castellino, Sharon M., Du, Yuhong, Fu, Haian, Mandawat, Anant, Xu, Chunhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643439/
https://www.ncbi.nlm.nih.gov/pubmed/33153480
http://dx.doi.org/10.1186/s13287-020-01984-1
_version_ 1783606279105675264
author Liu, Rui
Li, Dong
Sun, Fangxu
Rampoldi, Antonio
Maxwell, Joshua T.
Wu, Ronghu
Fischbach, Peter
Castellino, Sharon M.
Du, Yuhong
Fu, Haian
Mandawat, Anant
Xu, Chunhui
author_facet Liu, Rui
Li, Dong
Sun, Fangxu
Rampoldi, Antonio
Maxwell, Joshua T.
Wu, Ronghu
Fischbach, Peter
Castellino, Sharon M.
Du, Yuhong
Fu, Haian
Mandawat, Anant
Xu, Chunhui
author_sort Liu, Rui
collection PubMed
description BACKGROUND: Treatment-induced cardiotoxicity is a leading noncancer-related cause of acute and late onset morbidity and mortality in cancer patients on antineoplastic drugs such as melphalan—increasing clinical case reports have documented that it could induce cardiotoxicity including severe arrhythmias and heart failure. As the mechanism by which melphalan impairs cardiac cells remains poorly understood, here, we aimed to use cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) to investigate the cellular and molecular mechanisms of melphalan-induced cardiotoxicity. METHODS: hiPSC-CMs were generated and treated with clinically relevant doses of melphalan. To characterize melphalan-induced cardiotoxicity, cell viability and apoptosis were quantified at various treatment durations. Ca(2+) transient and contractility analyses were used to examine the alterations of hiPSC-CM function. Proteomic analysis, reactive oxygen species detection, and RNA-Sequencing were conducted to investigate underlying mechanisms. RESULTS: Melphalan treatment of hiPSC-CMs induced oxidative stress, caused Ca(2+) handling defects and dysfunctional contractility, altered global transcriptomic and proteomic profiles, and resulted in apoptosis and cell death. The antioxidant N-acetyl-l-cysteine attenuated these genomic, cellular, and functional alterations. In addition, several other signaling pathways including the p53 and transforming growth factor-β signaling pathways were also implicated in melphalan-induced cardiotoxicity according to the proteomic and transcriptomic analyses. CONCLUSIONS: Melphalan induces cardiotoxicity through the oxidative stress pathway. This study provides a unique resource of the global transcriptomic and proteomic datasets for melphalan-induced cardiotoxicity and can potentially open up new clinical mechanism-based targets to prevent and treat melphalan-induced cardiotoxicity.
format Online
Article
Text
id pubmed-7643439
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76434392020-11-06 Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells Liu, Rui Li, Dong Sun, Fangxu Rampoldi, Antonio Maxwell, Joshua T. Wu, Ronghu Fischbach, Peter Castellino, Sharon M. Du, Yuhong Fu, Haian Mandawat, Anant Xu, Chunhui Stem Cell Res Ther Research BACKGROUND: Treatment-induced cardiotoxicity is a leading noncancer-related cause of acute and late onset morbidity and mortality in cancer patients on antineoplastic drugs such as melphalan—increasing clinical case reports have documented that it could induce cardiotoxicity including severe arrhythmias and heart failure. As the mechanism by which melphalan impairs cardiac cells remains poorly understood, here, we aimed to use cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) to investigate the cellular and molecular mechanisms of melphalan-induced cardiotoxicity. METHODS: hiPSC-CMs were generated and treated with clinically relevant doses of melphalan. To characterize melphalan-induced cardiotoxicity, cell viability and apoptosis were quantified at various treatment durations. Ca(2+) transient and contractility analyses were used to examine the alterations of hiPSC-CM function. Proteomic analysis, reactive oxygen species detection, and RNA-Sequencing were conducted to investigate underlying mechanisms. RESULTS: Melphalan treatment of hiPSC-CMs induced oxidative stress, caused Ca(2+) handling defects and dysfunctional contractility, altered global transcriptomic and proteomic profiles, and resulted in apoptosis and cell death. The antioxidant N-acetyl-l-cysteine attenuated these genomic, cellular, and functional alterations. In addition, several other signaling pathways including the p53 and transforming growth factor-β signaling pathways were also implicated in melphalan-induced cardiotoxicity according to the proteomic and transcriptomic analyses. CONCLUSIONS: Melphalan induces cardiotoxicity through the oxidative stress pathway. This study provides a unique resource of the global transcriptomic and proteomic datasets for melphalan-induced cardiotoxicity and can potentially open up new clinical mechanism-based targets to prevent and treat melphalan-induced cardiotoxicity. BioMed Central 2020-11-05 /pmc/articles/PMC7643439/ /pubmed/33153480 http://dx.doi.org/10.1186/s13287-020-01984-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Rui
Li, Dong
Sun, Fangxu
Rampoldi, Antonio
Maxwell, Joshua T.
Wu, Ronghu
Fischbach, Peter
Castellino, Sharon M.
Du, Yuhong
Fu, Haian
Mandawat, Anant
Xu, Chunhui
Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells
title Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells
title_full Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells
title_fullStr Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells
title_full_unstemmed Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells
title_short Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells
title_sort melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643439/
https://www.ncbi.nlm.nih.gov/pubmed/33153480
http://dx.doi.org/10.1186/s13287-020-01984-1
work_keys_str_mv AT liurui melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells
AT lidong melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells
AT sunfangxu melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells
AT rampoldiantonio melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells
AT maxwelljoshuat melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells
AT wuronghu melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells
AT fischbachpeter melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells
AT castellinosharonm melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells
AT duyuhong melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells
AT fuhaian melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells
AT mandawatanant melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells
AT xuchunhui melphalaninducescardiotoxicitythroughoxidativestressincardiomyocytesderivedfromhumaninducedpluripotentstemcells